Accueil › Cancer du poumon non à petites cellules › Delaware

Essais cliniques pour Cancer du poumon non à petites cellules dans Delaware

21 études pour Cancer du poumon non à petites cellules recherchent des participants dans Delaware.

Villes dans Delaware

Texte officiel de l'étude (anglais)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
et 1 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Medical Oncology Hematology Consultants, Newark

Recrutement en coursPhase 1/2

Âges de 12 ans et plus · Tous sexes · Mis à jour le 2 oct. 2026 · NCT04585750

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
et 1 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT07388524

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
et 1 autres

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 1 oct. 2026 · NCT06498635

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Medical Oncology Hematology Consultants, PA, Newark

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 30 sept. 2026 · NCT07361497

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Medical Oncology Hematology Consultants, PA, Newark

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 28 sept. 2026 · NCT07144280

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark

Recrutement en coursPhase 3

Âges de 18 à 100 · Tous sexes · Mis à jour le 25 sept. 2026 · NCT05920356

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

ChristianaCare Helen F Graham Cancer Center and Research Institute, Newark

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06667076

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

ChristianaCare Health System, Newark

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT07154290

A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer

Research Site, Newark

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 25 sept. 2026 · NCT06868277

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Bayhealth Cancer Center- Kent, Dover
Bayhealth Cancer Center- Sussex, Milford

Recrutement en coursÉtude observationnelle

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07028489

An External Control Arm Study in Non-Small Cell Lung Cancer

Bayhealth Medical Center, Kent Campus, Dover
Bayhealth Medical Center- Sussex Campus, Milford

Recrutement en coursÉtude observationnelle

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT07174388

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Medical Oncology Hematology Consultants, PA, Newark

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 22 sept. 2026 · NCT06875310

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Research Site, Newark

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 18 sept. 2026 · NCT06692738

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

Research Site, Newark

Recrutement en coursPhase 3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 4 sept. 2026 · NCT07291037

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 3 juin 2026 · NCT05642572

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

Recrutement en coursPhase 2

Âges de 18 ans et plus · Tous sexes · Mis à jour le 6 mai 2026 · NCT06116682

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Bayhealth Hospital Kent Campus, Dover
Bayhealth Hospital Sussex Campus, Milford

Recrutement en coursPhase 2

18 Minutes · Tous sexes · Mis à jour le 5 mai 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
et 1 autres

Recrutement en coursPhase 2/3

Âges de 18 ans et plus · Tous sexes · Mis à jour le 5 mai 2026 · NCT06616584

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Beebe South Coastal Health Campus, Millville
Helen F Graham Cancer Center, Newark
Medical Oncology Hematology Consultants PA, Newark
et 1 autres

Recrutement en coursÉtude observationnelle

Âges de 18 ans et plus · Tous sexes · Mis à jour le 17 mars 2026 · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Newark

Recrutement en coursÉtude observationnelle

Tous âges · Tous sexes · Mis à jour le 28 oct. 2025 · NCT03452774

Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.